MARKET

NNVC

NNVC

Nanoviricides
AMEX
1.550
+0.080
+5.44%
After Hours: 1.550 0 0.00% 16:10 07/08 EDT
OPEN
1.450
PREV CLOSE
1.470
HIGH
1.560
LOW
1.450
VOLUME
436.29K
TURNOVER
--
52 WEEK HIGH
2.230
52 WEEK LOW
0.8500
MARKET CAP
35.62M
P/E (TTM)
-3.5388
1D
5D
1M
3M
1Y
5Y
1D
NanoViricides Price Target Announced at $6.00/Share by Noble Capital Markets
Dow Jones · 2d ago
NanoViricides Initiated at Outperform by Noble Capital Markets
Dow Jones · 2d ago
Noble Capital Markets Initiates Coverage On Nanoviricides with Outperform Rating, Announces Price Target of $6
Benzinga · 2d ago
NanoViricides initiated with an Outperform at Noble Capital
TipRanks · 2d ago
NanoViricides advances towards Phase II clinical trial of NV-387
TipRanks · 2d ago
NanoViricides Continues To Advance Broad-Spectrum Antiviral Drug NV-387 Towards Phase II Clinical Trial Of NV-387 Oral Gummies Formulation As Treatment For Current Bundibugyo Ebolavirus In DRC
Benzinga · 2d ago
Weekly Report: what happened at NNVC last week (0629-0703)?
Weekly Report · 2d ago
As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo
Barchart · 2d ago
More
About NNVC
NanoViricides, Inc. is a clinical-stage company. The Company is engaged in developing a class of drugs that it calls nanoviricides, using a platform technology based on the application of nanomedicine technologies to the complex issues of viral diseases. Its lead drug candidate is NV-387, a broad-spectrum antiviral drug that has demonstrated activity in lethal lung infection animal model studies of Coronavirus (COVID), Respiratory Syncytial Virus, Influenza, Orthopoxvirus model for Smallpox and MPox, and even in a humanized mice model for Measles. It is focused on advancing Phase II clinical trials. Its other advanced drug candidate is NV-HHV-1 for the treatment of Shingles rash. Its NV-CoV-2 and NV-CoV-2-R are drug candidates for the treatment of COVID. Its portfolio also includes NV-HIV-1, a novel mechanism Anti-HIV Drug Candidate. Its other drug candidates include treatment for viral infections, including Dengue viruses, Ebola viruses, among others.

Webull offers NanoViricides, Inc stock information, including AMEX: NNVC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NNVC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NNVC stock methods without spending real money on the virtual paper trading platform.